| | |
| |  | Dear The Startup Investor Reader,
After 11 years in stealth mode...
Experimenting with countless formulations...
And developing 27 "miracle" treatments for rare and deadly diseases...
This Harvard-trained doctor has finally revealed his new startup.
And his plan to bring all 27 treatments - which could be worth up to $1 billion each - to market.
Some in just 12 to 24 months.
Right now, his startup is valued at just $40 million.
And this doctor just released a limited number of shares for only $1 each.
He sat down with our very own Don Yocham to share all the details.
You can watch the interview - and get all the details on this very limited investing round - by clicking here.
Best,
Bob Keppel
Co-Founder, National Institute for Cannabis Investors | Please do not reply to this email. It was sent from an unmonitored mailbox.
You are receiving this e-mail at phanphuongthanh89.822152@blogger.com, as part of your subscription to The Startup Investor. To remove your email from this list: unsubscribe here.
To cancel, or for any other questions or requests, please contact our Customer Service team:
Online
Phone: 866-310-1498 (North America) 443-221-6766 (International)
Mail: The Startup Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201
Our Customer Service team is available Monday ‑ Friday between 9:00 AM and 5:00 PM ET.
© 2020 Angels & Entrepreneurs. All Rights Reserved.
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.
We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs. 1125 N Charles Street, Baltimore, MD 21201.
Website | Privacy Policy | Terms & Conditionshttp://link.e.angelsandentrepreneurs.com/wf/unsubscribe?upn=SVR9z3LgXEwEIVbUkFIuhfIKPV96lSE9UseWeXZ52MI4WY4eEn-2FXQBTN4MGeOz0GseIyndgO8daCHIwjmPi0EySCaAsypuV8RNEMBC-2FVlkhIHWMm1hw0uSXu4GkwGu9TAayNV8TQjBBSMH1t8f3YsH-2BEq2eiGipWZqe-2B8-2FM83BW0PLWRHvzNABv2mbfX6aOkyItyBOtTa4BFAzLHhoPWSAmf2PzLE0veAWjZPVZOiATJtvBGPiwQkOkO3cMk9XH5qGLRa3g5ZR0Nli4QbKP0GIThGGW60tczaWrkuNZGFrSX1qdReS8OXRsj8CXdyMhL8yoG4oUgmErhdYTbBCfl22086bEe3stgMOEctDE7NgcQoNoiHiJQVtKXul-2BhS2d4VelfCcaPHdgH2ZDSnMsvnoi1K1IRR9fXLEgMnUAkvGeUaPIMfR8OiwsrdoZeEgZl1PkX-2FYNBtRUIiLQae1tPkZLiarkXb-2Fc0LKZo74PSh5Vnbo5Xm0AhotkBYuiKmtP-2BEoN5KUPo-2BH-2BuDFe2Dzd3A3lglRf5YIoDuIzcLS11Ha8T67KxyeeED9gRZCagAlwMOVBObUGtdbC1S6CxeQlG1R8whwuArEiUrxaFqCp04ngFeMXeXBysD6kujBVn-2FTewo7yNan7-2B5-2FYN4mLqykuwAJzWNdyV70fYbsGxeL5W0A7FwmgH1vVpMRg6kscDJDz4d3nTJtzUrKDRFVkvYLPgZjqNSfSaMbY9ZGj70YoxCAUN2zuca0Ihvjr3X3DXZbtSFZeRea5d26GEJ9Xf9ZVperUfI3qbsVJ1415MuyNGZnJggfI7xSdknK8cUzOXTvGZXmMMpPivASjBX8-2F0jH8iAzIf3iu2YzTajRKHVWyPqOuDRJR6J1PSN52JYyv62tSRQjYoE-2FMU-2Bbm2SEkPcCBd3yCgH3b-2BEPSTgGdrbKPoHmx0zG0on0lsVnmWfMu9i5J8Ss7glYsEONxk1VRwiG8ezE95MFPpHzpxXEou2-2FPmmvrcq1mTc6YLHtkRlIFP2YeLlSwDjpdGUnuHuCLZSKJEhi-2BQNOM64lvvR2UIoFedokU-3D |
|
No comments:
Post a Comment